Recent study has reported that EBV infection could reduce the sensitivity of NPC cells to ferroptosis by upregulating the expression of SLC7A11 and GPX4 expression, and high GPX4 expression was correlated with poor clinical outcomes, suggesting a novel target in the treatment of NPC (Yuan et al., 2022). This evidence concerns the gene SLC7A11 and Epstein-Barr virus infection.